Protagonist Therapeutics, Inc Common Stock, Capital Shares Reserved for Future Issuance
Protagonist Therapeutics, Inc (PTGX) had Common Stock, Capital Shares Reserved for Future Issuance of 2.56 million shares as of 2016-12-31, per its 10-K filed 2017-03-07.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2017-03-07
- 2016-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.56M shares.
- 2016-09-30: Common Stock, Capital Shares Reserved for Future Issuance 2.57M shares.
- 2016-06-30: Common Stock, Capital Shares Reserved for Future Issuance 10.00M shares.
- 2015-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.58M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2016-12-31 | 2.56M shares 10-K · filed 2017-03-07 |
| 2016-09-30 | 2.57M shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 10.00M shares 10-Q · filed 2016-09-15 |
| 2015-12-31 | 6.58M shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |